Victoria R. Polonis - Concepedia

Author

Victoria R. Polonis

Walter Reed Army Institute of Research ORCID

Also Known As

Shelise Brooks, Su, Zhaohui, V Polonis, V R Polonis, V. Polonis, V. R. Polonis, V.R. POLONIS, V.R. Polonis, Victoria R. Polonis, Victoria Polonis

154

Publications

7.9K

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research Henry M. Jackson Foundation Jackson Foundation National Institutes of Health Armed Forces Research Institute of Medical Science

About

Victoria R. Polonis is an author at Walter Reed Army Institute of Research specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	47	4.3K
2	Natural Sciences	3	3	266
3	Allergy	3	3	1.1K
4	Health Sciences	1	1	30
5	Public Health	1	1	54

Victoria R. Polonis

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Human Immunodeficiency Virus Type 1<i>env</i>Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies Ming Li, Feng Gao, John R. Mascola, Journal of Virology Vaccine-elicited Neutralizing AntibodiesStandardized AssessmentsImmunodeficienciesImmunologyImmunotherapy	2005	1.1K
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies Michael S. Seaman, Holly Janes, Natalie Hawkins, Journal of Virology Diverse PanelViral DiagnosticsImmunologyPlasma PoolImmunotherapy	2009	636
Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular <i>env</i> Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa Ming Li, Jesus F. Salazar-Gonzalez, Cynthia A. Derdeyn, Journal of Virology	2006	351
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials David C. Montefiori, Chitraporn Karnasuta, Yunda Huang, The Journal of Infectious Diseases	2012	282
A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection Robert R. Redfield, Deborah L. Birx, Nzeera Ketter, New England Journal of Medicine	1991	245
Recommendations for the Design and Use of Standard Virus Panels To Assess Neutralizing Antibody Responses Elicited by Candidate Human Immunodeficiency Virus Type 1 Vaccines John R. Mascola, Patricia D’Souza, Peter B. Gilbert, Journal of Virology VaccinationStandard Virus PanelsVaccine DevelopmentImmune Assessment AssaysHuman Retrovirus	2005	236
Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC Tara G. Edmonds, Haitao Ding, Yuan Xing, Virology Natural SciencesHuman RetrovirusImmunologyAntiviral ResponseMolecular Biology	2010	182
Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades Miroslaw K. Górny, Constance Williams, Barbara Volsky, Journal of Virology	2002	177
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity Michael Joyce, Wei‐Hung Chen, Rajeshwer S. Sankhala, Cell Reports	2021	177
Safety and Immunogenicity of an HIV Subtype B and E Prime‐Boost Vaccine Combination in HIV‐Negative Thai Adults Sorachai Nitayaphan, Punnee Pitisuttithum, Chitraporn Karnasuta, The Journal of Infectious Diseases ImmunologyImmunodominanceImmunotherapyHuman RetrovirusHiv‐negative Thai Adults	2004	136

Page 1